Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dna X (SONM) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Dna X (SONM) over the last 8 years, with Q1 2025 value amounting to $621658.0.

  • Dna X's Treasury Shares fell 832.69% to $621658.0 in Q1 2025 from the same period last year, while for Mar 2025 it was $621658.0, marking a year-over-year decrease of 832.69%. This contributed to the annual value of $3769.0 for FY2024, which is 9447.24% down from last year.
  • Per Dna X's latest filing, its Treasury Shares stood at $621658.0 for Q1 2025, which was down 832.69% from $3769.0 recorded in Q4 2024.
  • In the past 5 years, Dna X's Treasury Shares ranged from a high of $2.7 million in Q1 2021 and a low of $3769.0 during Q4 2024
  • Its 5-year average for Treasury Shares is $648878.7, with a median of $347108.0 in 2021.
  • In the last 5 years, Dna X's Treasury Shares surged by 108824.5% in 2021 and then tumbled by 9447.24% in 2024.
  • Quarter analysis of 5 years shows Dna X's Treasury Shares stood at $347108.0 in 2021, then surged by 148.02% to $860888.0 in 2022, then plummeted by 92.08% to $68185.0 in 2023, then tumbled by 94.47% to $3769.0 in 2024, then soared by 16393.98% to $621658.0 in 2025.
  • Its Treasury Shares stands at $621658.0 for Q1 2025, versus $3769.0 for Q4 2024 and $51724.0 for Q3 2024.